Literature DB >> 4360943

Initiation characteristics for the synthesis of five T4 phage-specific messenger RNAs in vitro.

P J Natale, J M Buchanan.   

Abstract

The involvement of the nucleoside triphosphates in the initiation of the synthesis of the messenger ribonucleic acid of five T4 specific enzymes has been studied. Only one of these, the messenger RNA for deoxynucleosidemonophosphate kinase, can be initiated in the presence of one nucleoside triphosphate, namely ATP. All of the remaining four require the presence of at least two nucleoside triphosphates during the initiation period. The combination of ATP and UTP was best for the initiation of messenger RNA for dihydrofolate reductase, ATP and CTP for deoxycytidylate hydroxymethyltransferase and beta-glucosyltransferase, and ATP and GTP for alpha-glucosyltransferase. We have concluded that there is a great variation in the nucleotide composition and sequence of the initiation sites in T4 DNA. No correlation in the requirements of nucleoside triphosphates during the initiation period could be observed among the five systems studied according to their classification as one type or another of "early" T4 messenger RNA.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4360943      PMCID: PMC388018          DOI: 10.1073/pnas.71.2.422

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Transcription and translation of prereplicative bacteriophage T4 genes in vitro.

Authors:  P Z O'Farrell; L M Gold
Journal:  J Biol Chem       Date:  1973-08-10       Impact factor: 5.157

2.  The identification of prereplicative bacteriophage T4 proteins.

Authors:  P Z O'Farrell; L M Gold; W M Huang
Journal:  J Biol Chem       Date:  1973-08-10       Impact factor: 5.157

3.  Properties of phage T4 messenger RNA synthesized in the absence of protein synthesis.

Authors:  R F Peterson; P S Cohen; H L Ennis
Journal:  Virology       Date:  1972-04       Impact factor: 3.616

4.  Bacteriophage sigma factor for RNA polymerase.

Authors:  A A Travers
Journal:  Nature       Date:  1969-09-13       Impact factor: 49.962

5.  A new method for the large scale purification of Escherichia coli deoxyribonucleic acid-dependent ribonucleic acid polymerase.

Authors:  R R Burgess
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

6.  Synthesis of early RNA in bacteriophage T4-infected Escherichia coli B.

Authors:  R J Grasso; J M Buchanan
Journal:  Nature       Date:  1969-11-29       Impact factor: 49.962

7.  Characterization of a beta-galactosidase formed between a complementary protein and a peptide synthesized de novo.

Authors:  J K DeVries; G Zubay
Journal:  J Bacteriol       Date:  1969-03       Impact factor: 3.490

8.  The role of deoxyribonucleic acid in ribonucleic acid synthesis. XIV. A study of the initiation of ribonucleic acid synthesis.

Authors:  U Maitra; Y Nakata; J Hurwitz
Journal:  J Biol Chem       Date:  1967-11-10       Impact factor: 5.157

9.  Pyrimidine clusters on the transcribing strand of DNA and their possible role in the initiation of RNA synthesis.

Authors:  W Szybalski; H Kubinski; P Sheldrick
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1966

10.  E. coli sigma factor: a positive control element in phage T4 development.

Authors:  E K Bautz; F A Bautz; J J Dunn
Journal:  Nature       Date:  1969-09-06       Impact factor: 49.962

View more
  3 in total

1.  Transcriptional regulation of T4 bacteriophage-specific enzymes synthesized in vitro.

Authors:  P S Cohen; P J Natale; J M Buchanan
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

2.  The molecular biology of paramyxoviruses.

Authors:  D W Kingsbury
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

3.  Control of synthesis of mRNA's for T4 bacteriophage-specific dihydrofolate reductase and deoxycytidylate hydroxymethylase.

Authors:  H Witmer; A Baros; D Ende; M Dosmar
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.